跳至主要内容
临床试验/RPCEC00000084
RPCEC00000084已完成4 期

Impact of the Granulocytes Colony-Stimulating Factor(ior-LeukoCIM)in primary and secondary prophylaxis and post chemotherapy and/or radiotherapy neutropenia in oncohematological pediatric patients.

Center of Molecular Immunology(CIM)0 个研究点目标入组 372 人开始时间: 2009年7月24日最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
372

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
N/a: Single Arm Study. Masking: Open. Control Group: Uncontrolled. Assignment: Single Group. Purpose: Treatment

入排标准

年龄范围
1 year 至 18 years(—)
性别
All

入选标准

  • 1.Patients that fulfilled the diagnostic and/or condition of use criteria. 2.Patients with cytological and/or histological diagnosis of cancer of any localization that were receiving CT and/or RT. 3.Patients whose parents or tutors granted written consent for participation in the study. 4.Patients under 18 years old. 5.Will include patients of both sexes.

排除标准

  • 1.Patients with known hypersensitivity to products derived from E.Coli cells or other preparations of rG-CSF. 2.Acute or serious allergic status. 3.Patients with great tumor volumes in mediastinum in which concomitant CT and RT are needed.

研究者

发起方
Center of Molecular Immunology(CIM)

相似试验